LATENT TUBERCULOSIS SCREENING IN PATIENTS RECEIVING ANTI-TNFA THERAPY FOR INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Thomas, J.
Muruganandan, S.
Van Langenberg, D.
Thien, F.
机构：
来源：
RESPIROLOGY | 2012年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [31] IMPACT OF ANTI-TNFA EXPOSURE DURING PREGNANCY FOR MATERNAL INFLAMMATORY BOWEL DISEASE ON SEROLOGIC RESPONSE TO VACCINATION OF EXPOSED CHILDREN
    Duricova, Dana
    Dvorakova, Eva
    Kozeluhova, Jana
    Kohout, Pavel
    Mitrova, Katarina
    Durilova, Marianna
    Zarubova, Kristyna
    Hradsky, Ondrej
    Bronsky, Jiri
    Hradska, Nora
    Bronska, Eva
    Machkova, Nadezda
    Hruba, Veronika
    Bortlik, Martin
    Lukas, Martin
    Malickova, Karin
    Lukas, Milan
    GASTROENTEROLOGY, 2018, 154 (06) : S360 - S360
  • [32] Risk of tuberculosis with anti-TNF therapy in Indian patients with inflammatory bowel disease despite negative screening
    Giri, Suprabhat
    Bhrugumalla, Sukanya
    Shukla, Akash
    Gangadhar, Sagar
    Reddy, Srujan
    Angadi, Sumaswi
    Shinde, Leela
    Kale, Aditya
    ARAB JOURNAL OF GASTROENTEROLOGY, 2025, 26 (01) : 33 - 37
  • [33] CLINICAL FEATURES OF DEMYELINATION FOLLOWING ANTI-TNFA THERAPY
    Hendy, Peter
    Heerasing, Neel
    Walker, Gareth
    Goodhand, James
    Harrower, Tim
    Hobart, Jeremy
    Spiers, Alexander
    Coles, Alasdair
    Martin, Roswell
    Ahmad, Tariq
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A47 - A47
  • [34] Latent tuberculosis infection in Inflammatory Bowel Disease on the background of immunosuppressive therapy
    Sagynbaeva, Venera
    Lazebnik, Leonid
    Knyazev, Oleg
    Efremov, Leonid
    Dorofeev, Aleksei
    Rytikova, Natalya
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S40 - S40
  • [35] Immuno profile of Inflammatory bowel disease patient response to anti- TNFa therapy
    Pelczar, Penelope
    Ergen-Behr, Can
    Boettcher, Marius
    Machicote, Andres
    Sabihi, Morsal
    Manthey, Carolin
    Huber, Samuel
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 900 - 900
  • [36] Diagnosis and treatement of latent tuberculosis infection in patients with chronic Inflammatory Bowel Disease candidates for anti-TNFα therapy in a tuberculosis endemic country
    Mouslim, I
    Jioua, C.
    Touibi, A.
    Ouahid, S.
    Nejjari, F.
    Berrag, S.
    Tarik, A.
    Mouna, T.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1026 - I1026
  • [37] The effect of anti-TNFa therapy on spinal bone mineral density in patients with Crohn's disease.
    Rhim, AD
    Lichtenstein, GR
    Weinberg, AM
    Su, C
    Pazianas, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S454 - S454
  • [38] IMPROVING TUBERCULOSIS RE SCREENING IN INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY: A SINGLE CENTER QUALITY IMPROVEMENT INITIATIVE
    Drevno, David
    Hickok, Sherry
    Ali, Sabina
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S52 - S52
  • [39] Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti-TNF therapy in a tuberculosis endemic region
    Ye, Lingna
    Chapman, Thomas P.
    Wen, Zhenzhen
    Lin, Lang
    Qiu, Yun
    Liu, Zhanju
    Ran, Zhihua
    Qian, Jiaming
    Wu, Kaichun
    Gao, Xiang
    Hu, Pinjin
    Chen, Minhu
    Travis, Simon P. L.
    Cao, Qian
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (03) : 390 - 399
  • [40] Review article: Latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-Risks, screening, diagnosis and management
    Fehily, Sasha R.
    Al-Ani, Aysha H.
    Abdelmalak, Jonathan
    Rentch, Clarissa
    Zhang, Eva
    Denholm, Justin T.
    Johnson, Douglas
    Ng, Siew C.
    Sharma, Vishal
    Rubin, David T.
    Gibson, Peter R.
    Christensen, Britt
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (01) : 6 - 27
12345